Accuray (ARAY) Q4 2026 earnings summary

Executive summary

• Fiscal 2026 was marked by a comprehensive transformation plan focused on operational discipline, cost reduction, and strategic partnerships, delivering over $20M in cost and margin improvements, surpassing the $12M target.

• Despite challenging macroeconomic and geopolitical conditions, significant progress was made in strengthening the financial foundation, commercial leadership, and technology platforms.

• Service revenue and margins improved, with strong customer engagement and lead generation at ESTRO 2026, reinforcing market interest and commercial opportunities.

• Strategic partnerships expanded across imaging, software, engineering, and adaptive therapy, accelerating innovation and focus on core competencies.

• Comprehensive financing transaction with TCW Asset Management improved liquidity, reduced leverage, and provided covenant relief through December 2027.

Financial highlights

• Q4 net revenue was $100.9M, down 21% year-over-year; full-year revenue was $401.9M, down 12%.

• Q4 service revenue rose 6% to $60.1M, while product revenue fell 42% to $40.8M; full-year product revenue declined 27%, service revenue increased 4%.

• Q4 gross profit was $35.1M (34.8% margin); full-year gross profit was $111.5M (27.7% margin), both impacted by tariffs and one-time items.

• Adjusted EBITDA for Q4 was $12.9M, up from $9.4M; full-year adjusted EBITDA was $10.6M, down from $28.3M.

• Q4 net loss was $1.9M ($0.02/share); full-year net loss was $49.2M ($0.40/share), compared to $1.6M loss ($0.02/share) prior year.

Outlook and guidance

• No formal revenue or adjusted EBITDA guidance for fiscal 2027 due to ongoing macroeconomic and geopolitical uncertainties.

• Management expects continued growth in service revenue and margins, ongoing cost discipline, and benefits from transformation initiatives and strategic partnerships.

• Priorities include executing transformation initiatives, improving profitability, expanding recurring revenue, and creating long-term shareholder value.